CLPT — Clearpoint Neuro Inc
NASDAQ · Healthcare · Medical Devices
$15.30
+$0.40 (+2.68%)
Clearpoint Neuro Inc (CLPT) is a medical devices company listed on NASDAQ. It is led by Joseph Michael Burnett, based in 120 S. Sierra Avenue, Solana Beach, CA, United States, 92075, with about 172 employees. ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula. It also provides ClearPoint software, which guides the physician in surgical planning, device alignment, navigation to the target, and procedure monitoring; ClearPoint Prism Neuro laser therapy system to necrotize or coagulate soft tissue; and IRRAflow system, an active fluid exchange platform. In addition, the company offers consulting services to its pharmaceutical and other medical technology partners, such as benchtop testing, preclinical studies, clinical trial support, regulatory consultation, and translation from the preclinical to the clinical setting. It has licenses and collaboration agreements with Koninklijke Philips N.V., UCB Biopharma SRL, Clinical Laserthermia Systems AB, University of California, San Francisco, and NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
Latest reported CLPT revenue for 2025-09-30 was $8.9M. Net income was -$5.9M. Revenue was down 3.8% from 2025-06-30 to 2025-09-30. CLPT currently screens at market cap $371.0M.
Use this CLPT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CLPT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CLPT SEC filings page. Lician reads the product cache first so this HTML stays unique to Clearpoint Neuro Inc even when a live quote feed is slow.
About Clearpoint Neuro Inc
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula. It also provides ClearPoint software, which guides the physician in surgical planning, device alignment, navigation to the target, and procedure monitoring; ClearPoint Prism Neuro laser therapy system to necrotize or coagulate soft tissue; and IRRAflow system, an active fluid exchange platform. In addition, the company offers consulting services to its pharmaceutical and other medical technology partners, such as benchtop testing, preclinical studies, clinical trial support, regulatory consultation, and translation from the preclinical to the clinical setting. It has licenses and collaboration agreements with Koninklijke Philips N.V., UCB Biopharma SRL, Clinical Laserthermia Systems AB, University of California, San Francisco, and NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
CLPT Key Statistics
Market Cap
$370.97M
Volume
1.08M
Previous Close
$15.17
Day Range
$15.24 – $17.22
EPS
-$0.70
Revenue
$31.39M
Net Income
-$18.91M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+31.0%
Profit Margin
-60.3%
Employees
172
CLPT Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $31.39M | $23.95M | $20.55M | $16.30M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$18.91M | -$22.09M | -$16.43M | -$14.41M |
| EPS (Diluted) | -$0.70 | -$0.90 | -$0.68 | -$0.69 |
Total Assets
$39.19M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$20.10M
Operating Cash Flow
-$8.95M
Free Cash Flow
$0.00
Clearpoint Neuro Inc Company Information
- President, CEO & Director
- Joseph Michael Burnett
- Headquarters
- 120 S. Sierra Avenue, Solana Beach, CA, United States, 92075
- Website
- www.clearpointneuro.com
- Phone
- 888 287 9109
- IPO / Founded
- 2020-02-12
- Sector
- Healthcare
- Industry
- Medical Devices